Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlobalData Plc
  6. News
  7. Summary
    DATA   GB00B87ZTG26

GLOBALDATA PLC

(DATA)
  Report
Delayed London Stock Exchange  -  11:38 2022-09-27 am EDT
1070.00 GBX   +3.38%
09/27Globaldata : The US to lead North America's gas processing capacity additions by 2026, says GlobalData
PU
09/27Globaldata : Climate change and regulatory developments to drive South Korea reinsurance industry to reach $11.9bn in 2026, forecasts GlobalData
PU
09/21Globaldata : Lithium shortages to severely stall advanced electric transport projects such as flying taxis, says GlobalData
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlobalData : Global intraocular lens (IOL) market set to reach $5.2bn by 2030, says GlobalData

04/16/2021 | 01:51pm EDT
16 Apr 2021
Global intraocular lens (IOL) market set to reach $5.2bn by 2030, says GlobalData
Posted in Medical Devices

The global intraocular lens (IOL) market was valued at $3.5bn in 2020 and is set to increase at a compound annual growth rate (CAGR) of 4.1% due to the increasing sales of Monofocal, Multifocal, Toric and Polymethyl Methacrylate (PMMA) IOLs according to GlobalData, a leading data and analytics company.

This market valuation by GlobalData takes into account the negative impact of COVID-19, as year-over-year (YOY) sales for IOLs declined 17% in 2020 due to ophthalmic clinics closing during Q2 2020. In 2021, GlobalData anticipates the start of a 'surge period' in procedures and IOL sales to make up for postponements in 2020. However, the surge will not offset revenue losses until 2022, according to the company's recent report, 'Intraocular Lens (IOL), Global Outlook, 2015-2030'. The IOL market was more severely impacted than other markets sales as these devices rely mainly on elective procedures to generate revenue.

Eric Chapman, Senior Medical Devices Analyst at GlobalData, comments: 'In Q1 2020, elective procedures were postponed from around mid-March (two out of 12 weeks) and this two-week period negatively impact the overall sales of IOLs. By Q2 2020, as the number of new COVID-19 cases had reached a peak, many clinics were closed, and the market was down over 50%.'

Alcon is the market leader for IOL sales, followed by Johnson & Johnson, Hoya Corp, Carl Zeiss, and Bausch Health Companies. As such, these companies lost the most revenue due to the impact of COVID-19.

Chapman continues: 'GlobalData expects these players to retain their market position after the market recovers from the pandemic. Smaller manufacturers will continue to have a difficult time winning market share from market leaders Alcon and Johnson & Johnson, especially in the US.'

Disclaimer

GlobalData plc published this content on 16 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 April 2021 17:50:07 UTC.


© Publicnow 2021
All news about GLOBALDATA PLC
09/27Globaldata : The US to lead North America's gas processing capacity additions by 2026, say..
PU
09/27Globaldata : Climate change and regulatory developments to drive South Korea reinsurance i..
PU
09/21Globaldata : Lithium shortages to severely stall advanced electric transport projects such..
PU
09/08GLOBALDATA PLC : Ex-dividend day for interim dividend
FA
09/02GlobalData Closes Acquisition of TSL Research
MT
09/02GlobalData Plc completed the acquisition of TSL Research Group Limited.
CI
08/31Globaldata : Instant coffee to drive South Korea hot drinks market to $5 billion in 2026, ..
PU
08/31Globaldata : On-premise consumption will propel Japan hot drinks market at 4.7% CAGR throu..
PU
08/31Globaldata : Hybrid roles rose by 31% in Q2 2022 over Q1 2022, finds GlobalData
PU
08/26Autonomous mobile robots gaining traction
AQ
More news
Financials
Sales 2022 233 M 250 M 250 M
Net income 2022 - - -
Net Debt 2022 219 M 235 M 235 M
P/E ratio 2022 44,6x
Yield 2022 2,11%
Capitalization 1 203 M 1 293 M 1 293 M
EV / Sales 2022 6,11x
EV / Sales 2023 5,28x
Nbr of Employees 3 624
Free-Float 29,3%
Chart GLOBALDATA PLC
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1 070,00 GBX
Average target price 1 697,50 GBX
Spread / Average Target 58,6%
EPS Revisions
Managers and Directors
Michael Thomas Danson Chief Executive Officer & Director
Graham Charles Lilley Chief Financial Officer, Secretary & Director
Murray Legg Independent Non-Executive Chairman
Peter Martin Harkness Independent Non-Executive Director
Catherine Birkett Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
GLOBALDATA PLC-24.91%1 259
S&P GLOBAL, INC.-33.16%105 196
THOMSON REUTERS CORPORATION-5.97%50 183
RELX PLC-7.66%45 581
MSCI, INC.-31.96%33 872
WOLTERS KLUWER-5.44%23 382